GRFS Grifols SA: Margin operasi

Lambang korporat lan logo Grifols, S.A. (GRFS)

Grifols, S.A. (GRFS) modernized fractionation lines ensure maximum production efficiency. Operating margin fluctuations visualize current profitability, where the 16.40 indicator determines the parameter status. Financial stability is based on steady demand despite the debt load. Meanwhile, the company is implementing ESG environmental standards, strictly adhering to donation ethics and transparent compliance principles.

Grifols (GRFS): Rentabilitas dodolan operasi saka 04.07.2022 nganti 19.11.2026

GRFS (Grifols): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:GRFS, Grifols Biemat
Barang utama grifols.com

Operating margin is calculated as the ratio of earnings before interest and taxes to total revenue, determining the efficiency of covering production costs through core turnover. This metric reflects the ability of Grifols, S.A. (GRFS) to monetize high plant utilization and line modernization, allowing for an assessment of real cash flow sustainability through the rate of return from core operations.

Analisis pesaing

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Margin operasi PTGX (protagonist-inc.com)|IMVT: Rentabilitas dodolan miturut bathi operasi|KNSA - Rentabilitas operasi|Rentabilitas kegiatan operasi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Margin dodolan operasi|Aurinia Pharmaceuticals Inc. (AUPH) - Margin operasi|Margin dodolan operasi BCRX|Rentabilitas dodolan operasi Vera Therapeutics Inc VERA|Margin dodolan operasi DNTH (Dianthus Pharma)|Rentabilitas kegiatan operasi Pharvaris N.V.|AbCellera Biologics Inc - Margin dodolan operasi|Tourmaline Bio (TRML) - Rentabilitas dodolan operasi|PGEN - Rentabilitas operasi|Tingkat bathi operasi PHAR (Pharming Group NV)|NKTR: Margin operasi|Upstream Bio Corp - Tingkat bathi operasi|Rentabilitas operasi Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Rentabilitas kegiatan operasi|Margin operasi GOSS|Margin dodolan operasi KalVista Pharmaceuticals, Inc. KALV|Rentabilitas operasi Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Rentabilitas dodolan operasi|SVRA - Rentabilitas operasi|Rigel Pharmaceuticals - Rasio bathi operasi|AnaptysBio Corp (ANAB) - Rentabilitas operasi|ATXS - Rentabilitas kegiatan operasi|Rentabilitas operasi enGene Holdings Inc.|RAPT: Tingkat bathi operasi|Margin operasi JBIO|Margin dodolan operasi aclaristx.com ACRS|Rentabilitas operasi Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Rentabilitas dodolan operasi|Cabaletta Bio, Inc - Margin operasi|Rentabilitas dodolan operasi Ventyx Biosciences|THTX (theratech.com) - Margin dodolan operasi|Margin dodolan operasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Margin operasi|Rentabilitas dodolan operasi Agenus Inc. AGEN|Margin dodolan operasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com